The role of membrane transporters in ovarian cancer chemoresistance and prognosis

Expert Opinion on Drug Metabolism & Toxicology
Ela CerovskaPavel Soucek

Abstract

Ovarian cancer has the highest mortality rate of all cancers in women. There is currently no effective method for early diagnosis, limiting the precision of clinical expectations. Predictions of therapeutic efficacy are currently not available either. Specifically, the development of chemoresistance against conventional chemotherapy poses a fundamental complication. Some membrane transporters have been reported to influence chemoresistance, which is often associated with a poor prognosis. Areas covered: The aim of this article is to review the existing information about membrane transporters and their role in both ovarian cancer chemoresistance and its outcomes. We then highlight limitations of current methodologies and suggest alternatives providing avenues for future research. Expert opinion: Membrane transporters play an important role in development of chemoresistance and affect prognosis of ovarian cancer patients; however, due to variations in methodology and in patient populations, their specific roles have yet to be clarified. For further evaluation of the clinical utility of membrane transporters, it is essential to validate results and improve methods for marker assessment across laboratories. A promising area for fut...Continue Reading

References

Jan 1, 1999·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·S P Cole, R G Deeley
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·M KoolP Borst
Aug 17, 2000·Journal of the National Cancer Institute·P BorstJ Wijnholds
May 12, 2001·The Journal of Biological Chemistry·E B NeufeldH B Brewer
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Aug 2, 2002·Biochemical and Biophysical Research Communications·Armin PiehlerGerd Schmitz
Jun 25, 2003·Biochemical and Biophysical Research Communications·Jürgen J WenzelGerd Schmitz
Jan 30, 2004·International Journal of Cancer. Journal International Du Cancer·Shinji MizuaraiHidehito Kotani
Apr 20, 2004·Biochimica Et Biophysica Acta·Kristina E IleKenneth D Tew
Apr 23, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kentaro NakayamaYuji Takebayashi
May 18, 2004·Laboratory Investigation; a Journal of Technical Methods and Pathology·Sylvia AustTheresia Thalhammer
Oct 2, 2004·Journal of Inorganic Biochemistry·Roohangiz SafaeiStephen B Howell
Jan 15, 2005·Neurobiology of Disease·Sandrine MacéJean-François Deleuze
Apr 26, 2005·International Journal of Cancer. Journal International Du Cancer·Maarten T HuismanAlfred H Schinkel
May 5, 2005·Molecular and Cellular Biology·Yoshiyuki KuboAkihito Yamaguchi
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroshi TsudaSamuel C Mok
Oct 8, 2005·Cancer Biology & Therapy·Nicola F SmithAlex Sparreboom
Oct 11, 2005·Gynecologic Oncology·Alexander D GuminskiAnna Defazio
Jan 3, 2006·Cancer Letters·P BorstK van de Wetering
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Henrik GréenCurt Peterson
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
Apr 21, 2006·The Journal of Biological Chemistry·Kirstin KeusekottenMichael R Knittler
Jun 28, 2006·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Reina BendayanMoise Bendayan
Sep 5, 2006·Cancer Research·Shuzhong ZhangKathleen M Giacomini
Sep 8, 2006·Nature·Janakiraman KrishnamurthyNorman E Sharpless
Dec 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Pawel SurowiakHermann Lage
Feb 3, 2007·The Journal of Biological Chemistry·Nobuhiro BanNobuya Inagaki
Jun 22, 2007·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Kyoko OtaNobuo Yaegashi
Oct 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sharon MarshRobert Brown
Nov 9, 2007·Journal of Bioenergetics and Biomembranes·Saroj VelamakanniHendrik W van Veen
May 30, 2008·Clinical Pharmacology and Therapeutics·S D BakerA Sparreboom
Jun 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Liz Y HanAnil K Sood
Nov 11, 2008·Molecular Pharmacology·Christopher A LarsonStephen B Howell

❮ Previous
Next ❯

Citations

Mar 16, 2018·International Journal of Molecular Sciences·David VranaPavel Soucek
Jun 23, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·David LukanovićKatarina Černe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Biological Therapy
Karin JöhrerRichard Greil
Expert Opinion on Biological Therapy
Hans Martin SinghApostolia M Tsimberidou
© 2022 Meta ULC. All rights reserved